An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis.

ABSTRACT:

Background

Considering the heavy economic burden of osteoporotic fractures, the limits of healthcare resources, and the recent availability of new anti-osteoporosis drugs, there is continuing interest in economic evaluation studies of osteoporosis management strategies.

Objectives

This study aims to (1) systematically review recent economic evaluations of drugs for osteoporosis and (2) to apply an osteoporosis-specific guideline to critically appraise them.

Methods

A literature search was undertaken using PubMed, EMBASE, National Health Service Economic Evaluation database, and the Cost-Effectiveness Analysis Registry to identify original articles containing economic evaluations of anti-osteoporosis drugs, published between 1 July, 2013 and 31 December, 2019. A recent

SUBMITTER: Li N 

PROVIDER: S-EPMC7867562 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature